IL-13 receptor α2 contributes to development of experimental allergic asthma.
J Allergy Clin Immunol
; 132(4): 951-8.e1-6, 2013 Oct.
Article
in En
| MEDLINE
| ID: mdl-23763980
Key words
AHR; APTI; Airway hyperresponsiveness; Airway pressure-time index; BAL; BALF; Bronchoalveolar lavage; Bronchoalveolar lavage fluid; CLCA3; Chloride channel calcium activated 3; EMSA; Electrophoretic mobility shift assay; HDM; House dust mite; Human growth hormone; IL-13; IL-13 receptor; IL-13 receptor α1; IL-13 receptor α2; IL-13Rα1; IL-13Rα2; IL-4 receptor α; IL-4Rα; MCP; Membrane form of IL-13Rα2; Monocyte chemoattractant protein; PAS; Periodic acidSchiff; Quantitative PCR; Rat Clara cell 10 kDa; STAT6; Signal transducer and activator of transcription 6; Soluble form of IL-13Rα2; airway hyperresponsiveness; airway inflammation; hGH; lung; memIL-13Rα2; qPCR; rCC10; sIL-13Rα2
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Asthma
/
Interleukin-13 Receptor alpha2 Subunit
/
Hypersensitivity
/
Lung
Limits:
Animals
/
Female
/
Humans
/
Male
Language:
En
Journal:
J Allergy Clin Immunol
Year:
2013
Type:
Article